IR-Med (IRME) Cash & Equivalents (2020 - 2025)

IR-Med's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $63000.0 for Q2 2025.

• In Q2 2025, Cash & Equivalents fell 91.63% year-over-year to $63000.0; the TTM figure through Jun 2025 stood at $63000.0 (down 91.63% YoY), while the FY2024 annual figure was $129000.0, down 83.18% from the prior year.
• Cash & Equivalents came in at $63000.0 for Q2 2025 at IR-Med, up from $51000.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $4.1 million in Q2 2022 to a low of $51000.0 in Q1 2025.
• A 5-year average of $1.7 million and a median of $1.8 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 50.86% in 2021 and slumped 91.63% in 2025, its largest moves.
• IR-Med's Cash & Equivalents stood at $2.8 million in 2021, then advanced by 6.64% to $3.0 million in 2022, then sank by 74.45% to $767000.0 in 2023, then plunged by 83.18% to $129000.0 in 2024, then sank by 51.16% to $63000.0 in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $63000.0, $51000.0, and $129000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison